New research in the October 2023 issue of Journal of the National Comprehensive Cancer Network finds that intensive local-regional treatment to remove as much tumor as possible (known as «debulking»), in addition to standard systemic therapy, does not impact overall quality of life significantly for people with metastatic colorectal cancer.
More aggressive treatment doesn’t impact quality of life for metastatic colorectal cancer patients, says new study
New research in the October 2023 issue of Journal of the National Comprehensive Cancer Network finds that intensive local-regional treatment to remove as much tumor as possible (known as "debulking"), in addition to standard systemic therapy, does not impact overall quality of life significantly for people with metastatic colorectal cancer.